Emerging Therapies for Diabetes

Table of Contents

1 EXECUTIVE SUMMARY

• Scope and Methodology
  • Scope and Segmentation
  • Methodology
• Diabetes--An Overview
  • Types and Related Health Complications
  • Underlying Causes; Symptomatic Diagnosis and Treatment Approach
  • Key Findings

2 EMERGING THERAPIES IN DIABETES - TECHNOLOGY ANALYSIS

• Technology Primer
  • Current Diabetes Therapies
  • Noteworthy Emerging Diabetes Therapies
• Noteworthy Developments
  • Corporate Sector
  • Research Institutions and Universities
• Future Trends; Strategic Recommendations
  • Future Trends
  • Analyst Views and Strategic Recommendations

3 TECHNOLOGY ADOPTION FACTOR ANALYSIS

• Technology Drivers and Restraints
  • Pharmacotherapy
  • Insulin Therapy
  • Pancreas Transplant
  • Islet Cell Transplant
  • Artificial Pancreas
  • Gene Therapy
• Funding Analysis; Alliances; Mergers and Acquisitions
  • Funding
  • Alliances; Mergers; and Acquisitions

4 ASSESSMENT OF EMERGING THERAPIES AND SCREENING METHODS FOR DIABETES IN KEY COMPANIES AND UNIVERSITIES

• Technology Innovations in Companies--North America
  • Breakthrough Inhalable Insulin Therapy Relieves People of Painful Injections--USA
  • New Class of Oral Drugs for Diabetes--USA
  • Unique Diabetic Drug Based on Drug Repositioning Strategy for Type 2 Diabetes--Canada
  • Antidiabetic Drugs Promote Natural Metabolism by Mimicking Natural Hormones--USA
  • Oral Insulin Spray for the Treatment of Diabetes--Canada
  • Fast Acting Nasal Spray Formulation of Insulin for Diabetes Patients--USA
  • Novel Protein-Based Therapeutics for Treating Diabetes-Related Complications--USA
  • Noninvasive Screening Technology for Detecting Prediabetes and Diabetes--USA
  • Screening for Diabetes through Diagnostic Imaging of the Retina--USA
  • Novel Drug for the Treatment of Type 1 Diabetes with Potential Long-Term Benefits--USA
  • Unique Combination Drug for Patients with Type 2 Diabetes and Hypertension--Canada
  • Novel Combination Drug For Type 2 Diabetes--USA
  • Novel Small Molecule Drug Controls Blood Sugar without Causing Hypoglycemia--USA
  • Development of Bioartificial Pancreas for the Treatment of Type 1 Diabetes--USA
  • Integrated and Compact Insulin Delivery System--USA
• Technology Innovations in Companies--Europe
  • Novel Drug Addresses the Twin Problem of Diabetes and Obesity--France
  • Nanotechnology-Based Insulin Pump for Pain-Free Delivery of Insulin--Switzerland
  • Novel Range of Diabetes Care Products to Serve a Broader Patient Community--Denmark
  • Novel Antidiabetic Drug Targeting the Pancreatic Islet Dysfunction--Switzerland
  • Novel Drug Preserves Beta Cell Function in Type 1 Diabetes--Sweden
  • Novel Drugs that Treat Diabetes and its Complications Enter Clinical Trials--UK
• Technology Innovations in Companies--APAC
  • Healthy Neonatal Porcine Islet Cell Transplantation Technology for Insulin Production--Australia
  • Novel Peptide-Based Drug that Uniquely Targets Diabetes and its Resultant Complications--Australia
  • Topical Human Insulin Product for both Type 1 and Type 2 Diabetes--Australia
  • Combo Drugs Gaining Recognition for Treating Type 2 Diabetes--Japan
• Technology Innovations in Universities--World
  • Identification of Potential Therapeutic Targets for Treatment of Metabolic Syndrome--USA
  • New Method of Treating Diabetes Using a Naturally Occurring Fatty Acid--USA
  • Novel Designer Approach to Treat Type 1 Diabetes--USA
  • Use of Chromium as an Adjunct in the Pharmaceutical Therapy of Diabetes--USA
  • Study Identifies the Role of Brain in Diabetes Therapy--USA
  • Delivering Insulin Genes through a Unique Mechanism Boosts Gene Therapy of Diabetes--USA

5 PATENTS AND KEY CONTACTS

• Patents
  • US Patents
  • European Patents
• Key Contacts
  • Corporate Contacts
  • University Contacts

6 DECISION SUPPORT DATABASE

• Biotechnology--Companies; R&D; Funding--World
  • Number of Biotech Companies (2002-2012)
  • Government R&D Investment in Biotechnology (2002-2012)
  • Venture Capital Investment in Biotechnology (2002-2012)
• Population; Healthcare and Pharmaceutical R&D Expenditures--World
  • Total Population
  • Total Healthcare Expenditure
  • Pharmaceutical R&D Expenditure
• Pervalence of Diabetes and Related Health Risks--World
  • Diabetes Incidence (2002-2012)
  • Prevalence of Diabetes (2002-2012)
  • Diabetes Foot Ulcer Prevalence (2002-2012)
  • Obesity Prevalence (2002-2012)
  • Cataract Blindness (2002-2012)
  • Cardiovascular Prevalence (2002-2012)
• Organ Transplants--World
  • Number of Kidney Transplants (2002-2006)
  • Number of Pancreas Transplants (2002-2006)